Regulatory guidance for industry to prepare for the UK’s withdrawal from the EU
EMA and the European Commission publish first in a series of Q&As for companies
The European Medicines Agency (EMA) and the European Commission have published guidance to help pharmaceutical companies to prepare for the United Kingdom's withdrawal from the European Union. The guidance relates to both human and veterinary medicines.
The questions-and–answers document concerns information related to the location of establishment of a company in the context of centralised procedures and certain activities, including the location of orphan designation holders, qualified persons for pharmacovigilance (QPPVs) and companies’ manufacturing and batch release sites.
EMA is preparing a series of further guidance documents which will be published on its website in due course. Companies are advised to regularly check EMA’s dedicated webpage on the consequences of Brexit.
This first questions-and-answers document follows the publication of the European Commission/EMA notice to marketing authorisation holders of centrally authorised medicines for human and veterinary use on 2 May 2017.
Latest News from
Plastic Waste: a European strategy to protect the planet, defend our citizens & empower our industries17/01/2018 14:05:00
The first-ever Europe-wide strategy on plastics, now adopted, is a part of the transition towards a more circular economy.
New guidance on processing of applications for regulated products17/01/2018 12:44:00
An administrative guidance published this week sets out the principles that EFSA follows when processing applications for regulated products. This is part of EFSA’s continuous efforts to support applicants throughout the life-cycle of their applications.
Let us know what you think: EUIPO User Satisfaction Survey launched today16/01/2018 13:25:00
Every year EUIPO carries out a satisfaction survey to identify goals and priorities for improvement, as well as to assess the satisfaction of our users with the services we provide.
Payment services: Consumers to benefit from cheaper, safer and more innovative electronic payments15/01/2018 16:25:00
The revised Payment Services Directive (PSD2), which will apply as of 13 January 2018, aims to modernise Europe's payment services to the benefit of both consumers and businesses, so as to keep pace with this rapidly evolving market.